Many people on GLP-1 medications feel uncomfortable after eating large meals
Its tri-agonist structure allows researchers to examine the coordinated effects of multiple metabolic signaling systems within controlled laboratory environments, with an increased concentration suited for extended or higher-volume study protocols
Some research However, a new study, published in Diabetes, Obesity and Metabolism, indicates that people may maintain much of their weight loss after discontinuation, particularly if they transition to other treatments or lifestyle support
This is not a comprehensive list of side effects from these medications
Others, such as BPC-157 and Thymosin Beta-4, are classified as research chemicals and are not FDA-approved for supplements or medications (though you might be able to find them in online shops)
Monthly costs may be a barrier for some patients, and long-term affordability should be considered when planning treatment